세계의 유전체학 맞춤형 헬스 시장 보고서(2025년)

Genomics Personalized Health Global Market Report 2025

US $ 4,490 ￦ 6,387,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,232,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,077,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

유전체학 맞춤형 헬스 시장 규모는 향후 수년간 빠르게 성장하여 2029년까지 연평균 16.0%의 성장률로 336억 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 헬스케어 투자 증가, 유전체학 기술 채택 확대, 맞춤형 의료 적용 확대, 유전성 질환 유병률 증가, 바이오뱅크 확대, 만성질환 유병률 증가에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 웨어러블 기술과의 통합, 소비자 직접 유전자 검사의 성장, CRISPR과 유전자 편집의 발전, 유전체과 디지털 건강의 통합, 정밀의료 구상의 확대 등이 있습니다.

개인맞춤의료에 대한 관심이 높아지면서 향후 유전체학 개인맞춤의료 시장 확대가 가속화될 것으로 보입니다. 개인맞춤의료는 정밀의료라고도 불리며, 환자 개개인의 특성에 맞게 의료 개입을 맞춤화함으로써 헬스케어에 혁명을 불러일으키고 있습니다. 맞춤형 의료에 대한 수요가 급증하는 이유는 예방 의료로의 전환, 치료 결과 개선, 환자 참여 및 권한 부여, 경제적 이점, 만성 및 복합 질환의 유병률 증가에 기인합니다. 유전체 개인 맞춤형 건강은 개인의 유전자 데이터를 활용하여 예방과 진단에서 치료와 모니터링에 이르기까지 의료 개입을 조정함으로써 맞춤형 의료를 추진하는 데 있으며, 매우 중요한 역할을 하고 있습니다. 예를 들어 미국 기반의 비영리 단체인 Personalized Medicine Coalition이 2024년 2월에 보고한 바와 같이, FDA(식품의약국)는 2023년 희귀질환에 대한 16개의 혁신적인 개인맞춤형 치료제를 승인했습니다. 따라서 맞춤형 의료에 대한 수요 증가는 유전체학 맞춤형 헬스 시장의 성장을 지원하고 있습니다.

유전체학 맞춤형 헬스 시장의 주요 기업은 임상 차세대 염기서열 분석(NGS) 데이터의 3차 분석용 클라우드 기반 소프트웨어 등 혁신적인 제품 개발에 집중하며 경쟁 우위를 확보하고 있습니다. 임상 NGS 데이터는 시퀀싱 기술을 통해 얻은 유전 정보를 의미하며, 임상 현장에서 DNA 및 RNA 샘플의 고처리량 및 상세 분석을 가능하게 합니다. 예를 들어 DNA 시퀀싱 및 어레이 기반 기술을 전문으로 하는 미국 생명공학 기업 일루미나(Illumina)는 2023년 3월 임상 NGS 데이터의 3차 분석을 위해 설계된 클라우드 기반 소프트웨어인 커넥티드 인사이트(Connected Insights)를 발표했습니다. 이 플랫폼은 특히 종양학 용도에서 해석 및 보고 프로세스를 최적화하고 종합적인 유전체 프로파일링을 지원하며, Connected Insights는 다양한 타사 지식 기반을 통합하여 정확한 데이터 분석을 용이하게 하고, 정밀의료 구상의 효율성을 높입니다. 정밀의료 구상의 효율성을 향상시킵니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 유전체학 맞춤형 헬스 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 용도 산업의 분석
• 세계의 유전체학 맞춤형 헬스 시장 : 성장률 분석
• 세계의 유전체학 맞춤형 헬스 시장 실적 : 규모와 성장, 2019-2024
• 세계의 유전체학 맞춤형 헬스 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 유전체학 맞춤형 헬스 TAM(Total Addressable Market)

제6장 시장 세분화

• 세계의 유전체학 맞춤형 헬스 시장 : 테스트 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 종양학 검사
• 감염증 검사
• 희귀질환 검사
• 자가면역질환 검사
• 산과 검사
• 기타 테스트 유형
• 세계의 유전체학 맞춤형 헬스 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• NGS 플랫폼
• RT-PCR
• 마이크로어레이
• 유전자 분석기
• 세계의 유전체학 맞춤형 헬스 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 학술 조사기관
• 진단 센터
• 기타 최종사용자
• 세계의 유전체학 맞춤형 헬스 시장 종양학 검사의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 암게놈 프로파일링
• 액체생검 검사
• 종양 변이 부하 시험
• 유전자 바이오마커 검사
• 세계의 유전체학 맞춤형 헬스 시장 감염증 검사의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• PCR 검사
• 차세대 시퀀싱(NGS) 검사
• 미생물 게놈 프로파일링
• 세계의 유전체학 맞춤형 헬스 시장 희귀질환 검사의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 희귀질환 유전자 검사
• 유전성 질환 유전자 검사
• 표적 유전자 패널
• 세계의 유전체학 맞춤형 헬스 시장 자가면역질환 검사의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 자가면역질환 유전자 검사
• 면역 시스템 유전자 프로파일링
• HLA 타이핑 검사
• 세계의 유전체학 맞춤형 헬스 시장 산과 검사의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 비침습적 출생전 검사(NIPT)
• 선천 이상 유전자 검사
• 캐리어 스크리닝 검사
• 세계의 유전체학 맞춤형 헬스 시장, 기타 테스트 유형의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 심혈관유전자 검사
• 신경질환 검사
• 대사성 질환 유전자 검사

제7장 지역별·국가별 분석

• 세계의 유전체학 맞춤형 헬스 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 유전체학 맞춤형 헬스 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 유전체학 맞춤형 헬스 시장 : 경쟁 구도
• 유전체학 맞춤형 헬스 시장 : 기업 개요
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 대기업과 혁신적 기업

• PerkinElmer Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Exact Sciences Corporation
• QIAGEN N.V
• Natera Inc.
• Adaptive Biotechnologies Corporation
• Myriad Genetics Inc.
• NanoString Technologies Inc.
• Pacific Biosciences of California Inc.
• Personalis Inc.
• DNA Genotek Inc.
• Twist Bioscience Corporation
• GRAIL Inc.
• Eastern Biotech and Life Sciences

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 유전체학 맞춤형 헬스 시장 2029 : 새로운 기회를 제공하는 국가
• 유전체학 맞춤형 헬스 시장 2029 : 새로운 기회를 제공하는 부문
• 유전체학 맞춤형 헬스 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁의 전략

제36장 부록

KSA

영문 목차

영문목차

Genomics personalized health involves customizing medical care and treatments based on an individual's genomic data, taking into account their specific genetic characteristics, lifestyle choices, and environmental factors. This method utilizes progress in genomics, bioinformatics, and personalized medicine to offer more accurate and efficient healthcare solutions personalized to each person's genetic inclinations, susceptibilities, and responses to treatment.

The primary test types of genomics personalized health comprise oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, and others. Oncology testing involves employing genetic testing methods to identify cancer and ascertain its unique attributes, utilizing technologies such as NGS platforms, RT-PCR, microarray, and genetic analyzers. These tests cater to end users such as academic research institutes, diagnostic centers, and others.

The genomics personalized health market research report is one of a series of new reports from The Business Research Company that provides genomics personalized health market statistics, including the genomics personalized health industry global market size, regional shares, competitors with genomics personalized health market share, detailed genomics personalized health market segments, market trends, and opportunities, and any further data you may need to thrive in the genomics personalized health industry. These genomics personalized health market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genomics personalized health market size has grown rapidly in recent years. It will grow from $15.97 billion in 2024 to $18.58 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to advancements in genomics research, government funding, and support, a rise in chronic diseases, technological innovations, pharmaceutical industry investment, collaborations, and partnerships.

The genomics personalized health market size is expected to see rapid growth in the next few years. It will grow to $33.6 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to increasing healthcare investments, growing adoption of genomics technologies, expanding applications of personalized medicine, rising prevalence of genetic disorders, expansion of biobanks, and increasing prevalence of chronic diseases. Major trends in the forecast period include integration with wearable technology, growth of direct-to-consumer genetic testing, advancements in CRISPR and gene editing, integration of genomics with digital health, and expansion of precision medicine initiatives.

The increasing interest in personalized medicine is poised to drive the expansion of the genomics personalized health market in the future. Personalized medicine, also referred to as precision medicine, revolutionizes healthcare by customizing medical interventions to suit the unique characteristics of individual patients. The surge in demand for personalized medicine stems from a transition towards preventive healthcare, enhanced treatment outcomes, heightened patient involvement and empowerment, economic advantages, and the escalating prevalence of chronic and intricate ailments. Genomics personalized health plays a pivotal role in advancing personalized medicine by harnessing individual genetic data to tailor medical interventions, spanning from preventive measures and diagnosis to treatment and monitoring. For example, in February 2024, as reported by the Personalized Medicine Coalition, a non-profit organization based in the US, the Food and Drug Administration (FDA) sanctioned 16 innovative personalized therapies for rare diseases in 2023, in contrast to six in 2022. Hence, the escalating demand for personalized medicine underpins the growth of the genomics personalized health market.

Leading companies in the genomics personalized health market are focusing on developing innovative products, such as cloud-based software for tertiary analysis of clinical next-generation sequencing (NGS) data, to gain a competitive edge. Clinical NGS data refers to genetic information obtained through sequencing technologies, enabling high-throughput, detailed analysis of DNA or RNA samples in clinical settings. For example, in March 2023, Illumina, a US-based biotechnology company specializing in DNA sequencing and array-based technologies, launched Connected Insights, a cloud-based software designed for the tertiary analysis of clinical NGS data. This platform aims to optimize the interpretation and reporting processes, particularly for oncology applications, and supports comprehensive genomic profiling. Connected Insights integrates various third-party knowledge bases, facilitating accurate data analysis and improving the efficiency of precision care initiatives.

In January 2022, Exact Sciences Corp., a US-based biotechnology research company, completed the acquisition of PreventionGenetics for an undisclosed sum. This strategic move was intended to enhance Exact Sciences' capabilities in cancer screening and diagnostics, with a specific focus on hereditary cancer testing, in order to further the cause of personalized healthcare and promote early cancer detection. PreventionGenetics, also based in the US, is a biotechnology research company specializing in genomics personalized health.

Major companies operating in the genomics personalized health market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Quest Diagnostics, Agilent Technologies Inc., Lonza Group, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Personalis Inc., DNA Genotek Inc., Twist Bioscience Corporation, GRAIL Inc., Eastern Biotech and Life Sciences, INVITAE Corporation, Genetic Technologies Limited, XCode Life Sciences Private Limited, Biome Inc., BGI Genomics Co. Ltd.

North America was the largest region in the personalized health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics personalized health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the genomics personalized health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The genomics personalized health market consists of revenues earned by entities by providing services such as genomic sequencing, bioinformatics analysis, genetic testing, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomics personalized health market also includes sales of DNA sequencing kits, genomic data management solutions, pharmacogenomics tests, personalized wellness and nutrition products, and companion diagnostics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomics Personalized Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomics personalized health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomics personalized health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomics personalized health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: Oncology Testing; Infectious Disease Testing; Orphan Disease Testing; Autoimmune Disease Testing; Obstetrics Testing; Other Test Type
• 2) By Technology: NGS platforms; RT-PCR; Microarray; Genetic Analyzers
• 3) By End User: Academic Research Institutes; Diagnostic Centers; Other End Users
• Subsegments:
• 1) Oncology Testing: Cancer Genomic Profiling; Liquid Biopsy Testing; Tumor Mutational Burden Testing; Genetic Biomarker Testing
• 2) Infectious Disease Testing: PCR-Based Tests; Next-Generation Sequencing (NGS) Tests; Microbial Genomic Profiling
• 3) Orphan Disease Testing: Genetic Screening For Rare Diseases; Genetic Testing For Inherited Disorders; Targeted Gene Panels
• 4) Autoimmune Disease Testing: Genetic Screening For Autoimmune Conditions; Immune System Gene Profiling; HLA Typing Tests
• 5) Obstetrics Testing: Non-Invasive Prenatal Testing (NIPT); Genetic Screening For Birth Defects; Carrier Screening Tests
• 6) Other Test Type: Cardiovascular Genetic Testing; Neurological Disease Testing; Metabolic Disease Genetic Testing
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Quest Diagnostics; Agilent Technologies Inc.; Lonza Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genomics Personalized Health Market Characteristics

3. Genomics Personalized Health Market Trends And Strategies

4. Genomics Personalized Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Genomics Personalized Health Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genomics Personalized Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genomics Personalized Health Market Growth Rate Analysis
• 5.4. Global Genomics Personalized Health Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genomics Personalized Health Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genomics Personalized Health Total Addressable Market (TAM)

6. Genomics Personalized Health Market Segmentation

• 6.1. Global Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology Testing
• Infectious Disease Testing
• Orphan Disease Testing
• Autoimmune Disease Testing
• Obstetrics Testing
• Other Test Type
• 6.2. Global Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• NGS platforms
• RT-PCR
• Microarray
• Genetic Analyzers
• 6.3. Global Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic Research Institutes
• Diagnostic Centers
• Other End User
• 6.4. Global Genomics Personalized Health Market, Sub-Segmentation Of Oncology Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Genomic Profiling
• Liquid Biopsy Testing
• Tumor Mutational Burden Testing
• Genetic Biomarker Testing
• 6.5. Global Genomics Personalized Health Market, Sub-Segmentation Of Infectious Disease Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR-Based Tests
• Next-Generation Sequencing (NGS) Tests
• Microbial Genomic Profiling
• 6.6. Global Genomics Personalized Health Market, Sub-Segmentation Of Orphan Disease Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Screening For Rare Diseases
• Genetic Testing For Inherited Disorders
• Targeted Gene Panels
• 6.7. Global Genomics Personalized Health Market, Sub-Segmentation Of Autoimmune Disease Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Screening For Autoimmune Conditions
• Immune System Gene Profiling
• HLA Typing Tests
• 6.8. Global Genomics Personalized Health Market, Sub-Segmentation Of Obstetrics Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Invasive Prenatal Testing (NIPT)
• Genetic Screening For Birth Defects
• Carrier Screening Tests
• 6.9. Global Genomics Personalized Health Market, Sub-Segmentation Of Other Test Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Genetic Testing
• Neurological Disease Testing
• Metabolic Disease Genetic Testing

7. Genomics Personalized Health Market Regional And Country Analysis

• 7.1. Global Genomics Personalized Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genomics Personalized Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomics Personalized Health Market

• 8.1. Asia-Pacific Genomics Personalized Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomics Personalized Health Market

• 9.1. China Genomics Personalized Health Market Overview
• 9.2. China Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomics Personalized Health Market

• 10.1. India Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomics Personalized Health Market

• 11.1. Japan Genomics Personalized Health Market Overview
• 11.2. Japan Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomics Personalized Health Market

• 12.1. Australia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomics Personalized Health Market

• 13.1. Indonesia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomics Personalized Health Market

• 14.1. South Korea Genomics Personalized Health Market Overview
• 14.2. South Korea Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomics Personalized Health Market

• 15.1. Western Europe Genomics Personalized Health Market Overview
• 15.2. Western Europe Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomics Personalized Health Market

• 16.1. UK Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomics Personalized Health Market

• 17.1. Germany Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomics Personalized Health Market

• 18.1. France Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomics Personalized Health Market

• 19.1. Italy Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomics Personalized Health Market

• 20.1. Spain Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomics Personalized Health Market

• 21.1. Eastern Europe Genomics Personalized Health Market Overview
• 21.2. Eastern Europe Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomics Personalized Health Market

• 22.1. Russia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomics Personalized Health Market

• 23.1. North America Genomics Personalized Health Market Overview
• 23.2. North America Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomics Personalized Health Market

• 24.1. USA Genomics Personalized Health Market Overview
• 24.2. USA Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomics Personalized Health Market

• 25.1. Canada Genomics Personalized Health Market Overview
• 25.2. Canada Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomics Personalized Health Market

• 26.1. South America Genomics Personalized Health Market Overview
• 26.2. South America Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomics Personalized Health Market

• 27.1. Brazil Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomics Personalized Health Market

• 28.1. Middle East Genomics Personalized Health Market Overview
• 28.2. Middle East Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomics Personalized Health Market

• 29.1. Africa Genomics Personalized Health Market Overview
• 29.2. Africa Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomics Personalized Health Market Competitive Landscape And Company Profiles

• 30.1. Genomics Personalized Health Market Competitive Landscape
• 30.2. Genomics Personalized Health Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lonza Group Overview, Products and Services, Strategy and Financial Analysis

31. Genomics Personalized Health Market Other Major And Innovative Companies

• 31.1. PerkinElmer Inc.
• 31.2. Illumina Inc.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Exact Sciences Corporation
• 31.5. QIAGEN N.V
• 31.6. Natera Inc.
• 31.7. Adaptive Biotechnologies Corporation
• 31.8. Myriad Genetics Inc.
• 31.9. NanoString Technologies Inc.
• 31.10. Pacific Biosciences of California Inc.
• 31.11. Personalis Inc.
• 31.12. DNA Genotek Inc.
• 31.13. Twist Bioscience Corporation
• 31.14. GRAIL Inc.
• 31.15. Eastern Biotech and Life Sciences

32. Global Genomics Personalized Health Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomics Personalized Health Market

34. Recent Developments In The Genomics Personalized Health Market

35. Genomics Personalized Health Market High Potential Countries, Segments and Strategies

• 35.1 Genomics Personalized Health Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genomics Personalized Health Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genomics Personalized Health Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료